medRxiv PreprintsInternational19 November 2026
ClinDataBench: Benchmarking Large Language Model Agents in Clinical Trial Analysis Dataset Construction
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
A new drug reaches patients only after the U.S. Food and Drug Administration (FDA) has reviewed its trial evidence, which every application carries as analysis datasets in the Clinical Data Interchange Standards Consortium (CDISC) Analysis Data Model (ADaM) format that programmers derive by hand from raw trial data, a statistical analysis plan (SAP) and dataset specifications. Coding agents built on large language models (LLMs) could take over this work, and a slow-changing industry will adopt them only with evidence of what they get right and wrong. However, work on large language models (LLM
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.